Kennedy Institute of Rheumatology
A world-leading medical research centre where discovery research drives the development of transformative therapies for chronic inflammatory and degenerative disease.
240 Staff, students and academic visitors
£70M+ in Research Income
cIAP1/2 inhibition synergizes with TNF inhibition in autoimmunity by down-regulating IL-17A and inducing Tregs.
Kawalkowska JZ. et al, (2019), Sci Adv, 5
Friedrich M. et al, (2019), Immunity, 50, 992 - 1006
Active immunisation targeting nerve growth factor attenuates chronic pain behaviour in murine osteoarthritis.
von Loga IS. et al, (2019), Ann Rheum Dis
de Santiago I. et al, (2019), Int J Cancer